<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03401931</url>
  </required_header>
  <id_info>
    <org_study_id>HSJ_AIFIB_2017</org_study_id>
    <nct_id>NCT03401931</nct_id>
  </id_info>
  <brief_title>Artificial Intelligence Use for the Detection of Atrial Fibrillation Drivers</brief_title>
  <acronym>AI Fib</acronym>
  <official_title>Artificial Intelligence Use for the Detection of Atrial Fibrillation Drivers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital St. Joseph, Marseille, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital St. Joseph, Marseille, France</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      pilot clinical study, multicenter, prospective, open, nonrandomized
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The hypothesis is that ablation targeting PVI alone for the treatment of persistent AF is
      less efficient that ablation targeting electrophysiologic areas with
      spatio-temporal-dispersion with or without PVI
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    another design of protocole is submitted for approuval before the start date
  </why_stopped>
  <start_date type="Actual">January 9, 2018</start_date>
  <completion_date type="Actual">January 9, 2018</completion_date>
  <primary_completion_date type="Actual">January 9, 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>AF termination</measure>
    <time_frame>during the ablation procedure</time_frame>
    <description>conversion to sinus rhythm or stable atrial tachycardia</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>AT termination</measure>
    <time_frame>during the ablation procedure</time_frame>
    <description>conversion to sinus rhythm</description>
  </secondary_outcome>
  <enrollment type="Actual">0</enrollment>
  <condition>Fibrillation, Atrial</condition>
  <condition>To Evaluate the Intraoperative Efficiency of the AIFIB Software in the Detection of Atrial Fibrillation Driver During an Ablation Procedure</condition>
  <eligibility>
    <study_pop>
      <textblock>
        major patient with an indication of AF or AT ablation
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria: major patient with an indication of AF or AT ablation -

        Exclusion Criteria:

        -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julien SEITZ, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hopital saint Joseph</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hopital d'Aix en Provence</name>
      <address>
        <city>Aix-en-Provence</city>
        <zip>13100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Nice</name>
      <address>
        <city>Nice</city>
        <zip>06000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Isala Hospital</name>
      <address>
        <city>Zwolle</city>
        <state>Netherland</state>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>January 9, 2018</study_first_submitted>
  <study_first_submitted_qc>January 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 17, 2018</study_first_posted>
  <last_update_submitted>April 24, 2020</last_update_submitted>
  <last_update_submitted_qc>April 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital St. Joseph, Marseille, France</investigator_affiliation>
    <investigator_full_name>SEITZ JULIEN</investigator_full_name>
    <investigator_title>Cardiologist, Electrophysiology specialist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

